CN113142563A - 一种含可溶性膳食纤维的预消化型全营养配方食品 - Google Patents
一种含可溶性膳食纤维的预消化型全营养配方食品 Download PDFInfo
- Publication number
- CN113142563A CN113142563A CN202110415741.6A CN202110415741A CN113142563A CN 113142563 A CN113142563 A CN 113142563A CN 202110415741 A CN202110415741 A CN 202110415741A CN 113142563 A CN113142563 A CN 113142563A
- Authority
- CN
- China
- Prior art keywords
- soluble dietary
- containing soluble
- dietary fiber
- predigested
- oligosaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013325 dietary fiber Nutrition 0.000 title claims abstract description 39
- 235000013305 food Nutrition 0.000 title claims abstract description 35
- 235000015097 nutrients Nutrition 0.000 claims abstract description 18
- 235000016709 nutrition Nutrition 0.000 claims abstract description 18
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 15
- 239000008158 vegetable oil Substances 0.000 claims abstract description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 14
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 13
- 235000010755 mineral Nutrition 0.000 claims abstract description 13
- 239000011707 mineral Substances 0.000 claims abstract description 13
- 239000003094 microcapsule Substances 0.000 claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 12
- 235000013336 milk Nutrition 0.000 claims abstract description 10
- 239000008267 milk Substances 0.000 claims abstract description 10
- 210000004080 milk Anatomy 0.000 claims abstract description 10
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 9
- 239000004376 Sucralose Substances 0.000 claims abstract description 8
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 8
- 239000000835 fiber Substances 0.000 claims abstract description 8
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 8
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 8
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 8
- 235000019408 sucralose Nutrition 0.000 claims abstract description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000010489 acacia gum Nutrition 0.000 claims abstract description 5
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims abstract description 5
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 5
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 5
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 21
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 16
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 14
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 11
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 9
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 8
- 229940042585 tocopherol acetate Drugs 0.000 claims description 8
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 7
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 7
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 7
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 7
- 239000011706 ferric diphosphate Substances 0.000 claims description 7
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 7
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 7
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 7
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 7
- 239000001095 magnesium carbonate Substances 0.000 claims description 7
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 7
- 229940099596 manganese sulfate Drugs 0.000 claims description 7
- 239000011702 manganese sulphate Substances 0.000 claims description 7
- 235000007079 manganese sulphate Nutrition 0.000 claims description 7
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 7
- 239000001103 potassium chloride Substances 0.000 claims description 7
- 235000011164 potassium chloride Nutrition 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- 239000011781 sodium selenite Substances 0.000 claims description 7
- 229960001471 sodium selenite Drugs 0.000 claims description 7
- 235000015921 sodium selenite Nutrition 0.000 claims description 7
- 239000011787 zinc oxide Substances 0.000 claims description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 5
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 5
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 5
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 5
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 claims description 5
- 229960004874 choline bitartrate Drugs 0.000 claims description 5
- 239000011666 cyanocobalamin Substances 0.000 claims description 5
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 5
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 5
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 5
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 5
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 5
- 229960000342 retinol acetate Drugs 0.000 claims description 5
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 5
- 235000019173 retinyl acetate Nutrition 0.000 claims description 5
- 239000011770 retinyl acetate Substances 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 235000019192 riboflavin Nutrition 0.000 claims description 5
- 239000002151 riboflavin Substances 0.000 claims description 5
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 claims description 5
- 239000011652 vitamin K3 Substances 0.000 claims description 5
- 235000012711 vitamin K3 Nutrition 0.000 claims description 5
- 229940041603 vitamin k 3 Drugs 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 239000005913 Maltodextrin Substances 0.000 claims description 4
- 229920002774 Maltodextrin Polymers 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 229940035034 maltodextrin Drugs 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 108010016626 Dipeptides Proteins 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 108010038807 Oligopeptides Proteins 0.000 claims description 2
- 102000015636 Oligopeptides Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 239000004365 Protease Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 2
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 2
- 239000005018 casein Substances 0.000 claims description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 2
- 235000021240 caseins Nutrition 0.000 claims description 2
- 235000013373 food additive Nutrition 0.000 claims description 2
- 239000002778 food additive Substances 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 235000021388 linseed oil Nutrition 0.000 claims description 2
- 239000000944 linseed oil Substances 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 235000019198 oils Nutrition 0.000 claims description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 2
- 229960005055 sodium ascorbate Drugs 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- 235000020238 sunflower seed Nutrition 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 238000004945 emulsification Methods 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 6
- 235000005911 diet Nutrition 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 230000037213 diet Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000000668 Chronic Pancreatitis Diseases 0.000 abstract description 4
- 206010033645 Pancreatitis Diseases 0.000 abstract description 4
- 206010033647 Pancreatitis acute Diseases 0.000 abstract description 4
- 206010033649 Pancreatitis chronic Diseases 0.000 abstract description 4
- 201000003229 acute pancreatitis Diseases 0.000 abstract description 4
- 230000007661 gastrointestinal function Effects 0.000 abstract description 4
- 230000007812 deficiency Effects 0.000 abstract description 3
- 230000002757 inflammatory effect Effects 0.000 abstract description 3
- 208000028774 intestinal disease Diseases 0.000 abstract description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 235000013350 formula milk Nutrition 0.000 description 27
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- 239000002211 L-ascorbic acid Substances 0.000 description 6
- 235000000069 L-ascorbic acid Nutrition 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 6
- 208000002720 Malnutrition Diseases 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 235000000824 malnutrition Nutrition 0.000 description 5
- 230000001071 malnutrition Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 208000015380 nutritional deficiency disease Diseases 0.000 description 5
- -1 vitamin dl-alpha-tocopherol acetate Chemical class 0.000 description 4
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- 235000019700 dicalcium phosphate Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010033646 Acute and chronic pancreatitis Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000017228 Gastrointestinal motility disease Diseases 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229910000861 Mg alloy Inorganic materials 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000020616 amino acid formula Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000020802 micronutrient deficiency Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pediatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明适用于营养食品技术领域，提供了一种含可溶性膳食纤维的预消化型全营养配方食品，每100g含有：低纤维碳水化合物52.5‑68.5g，乳肽12‑22g，中链甘油三酯4‑8g，植物油微囊粉4.5‑10g，矿物质预混料4.0‑6.0g，维生素预混料0.8‑1.2g，阿拉伯胶0.5‑1.0g，食用香精0.02‑0.10g，三氯蔗糖0.01‑0.05g。其产品组分全面、丰富，易于机体消化吸收，特别添加低聚果糖、低聚异麦芽糖、低聚木糖等可溶性膳食纤维，通过各组分的协同作用，在保证病人合理膳食的基础上最大限度减少病人肠道负担，促进急慢性胰腺炎、腹泻、炎症性肠道疾病等胃肠道功能不足或部分缺失状态下的患者疾病的康复。
Description
技术领域
本发明属于营养食品技术领域，尤其涉及一种含可溶性膳食纤维的预消化型全营养配方食品。
背景技术
营养不良(malnutrition)是指因营养摄入不足、过剩或营养比例异常，与机体的营养需求不协调，因而导致身体状况和精神状态下降的临床综合征，包括营养不足、肥胖和超重以及微量营养素缺乏。随着我国社会老龄化进程不断加快，老年人营养不良问题日益突出，住院患者尤其是老年人营养不良发病率高。此外，饮食结构不合理、生活不规律、运动量减少、不良生活嗜好(烟酒、熬夜)和饮食习惯(高盐、高脂)、食品污染等因素导致非住院人群中各种膳食相关慢性疾病的发病率也呈明显上升趋势，患病人群日趋年轻化、儿童化，庞大的医疗费用支出已经成为国家、社会和家庭沉重的经济负担。
根据GB 29922《食品安全国家标准特殊医学用途配方食品通则》定义：特殊医学用途配方食品是为了满足进食受限、消化吸收障碍、代谢紊乱或特定疾病状态人群对营养素或膳食的特殊需要，专门加工配制而成的配方食品。该类产品必须在医生或临床营养师指导下，单独食用或与其他食品配合食用。主要包含三种：全营养配方食品、特定全营养配方食品、非全营养配方食品。其中，全营养配方食品按氮源可分为三大类：氨基酸型、短肽型、整蛋白型。
肠内营养制剂的选择应根据胃肠功能状况慎重选用。整蛋白型肠内营养配方对肠粘膜的更新和修复有刺激作用，较肽类或纯氨基酸配方更强，但这类产品要求胃肠道具备较正常的消化吸收能力。而对于急慢性胰腺炎、腹泻、炎症性肠道疾病等胃肠道功能不足或部分缺失状态下的患者，特别是危重症病人，常有呕吐和胃排空延迟等现象，此时完全给予大分子聚合物肠内营养配方可能导致部分患者胃潴留、呕吐、腹胀、腹泻、便秘等并发症的发生率增加，而早期使用预消化型肠内营养配方可明显减轻患者的胃肠道负担，且能保证完整而足量的营养支持，还能有效促进胃肠道功能的恢复，减少并发症的发生。
近年来大量临床和文献表明，膳食纤维是多种肠道疾病的重要保护因素。膳食纤维可加快结肠运输，产生短链脂肪酸，正向调节肠道菌群等生理作用，现临床已广泛用于危重症病人、炎症性肠病等胃肠动力障碍病人的辅助治疗。目前市场上和文献报道中并无针对急慢性胰腺炎、腹泻、炎症性肠道疾病等胃肠道功能不足或部分缺失状态下的患者的含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品。
发明内容
本发明提供一种含可溶性膳食纤维的预消化型全营养配方食品，旨在解决现有技术存在的问题。
本发明是这样实现的，一种含可溶性膳食纤维的预消化型全营养配方食品，每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有：低纤维碳水化合物52.5-68.5g，乳肽12-22g，中链甘油三酯4-8g，植物油微囊粉4.5-10g，矿物质预混料4.0-6.0g，维生素预混料0.8-1.2g，阿拉伯胶0.5-1.0g，食用香精0.02-0.10g，三氯蔗糖0.01-0.05g。
优选的，每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有：低纤维碳水化合物63.635g，乳肽17.5g，中链甘油三酯5.0g，植物油微囊粉7.0g，矿物质预混料5.0g，维生素预混料1.0g，阿拉伯胶0.8g，食用香精0.05g，三氯蔗糖0.015g。
优选的，每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有麦芽糊精56-62g、低聚果糖1.5-2.5g。
优选的，每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有麦芽糊精61.635g、低聚果糖2.0g。
优选的，所述乳肽经蛋白酶水解后以二肽、三肽和寡肽为主，分子量Mw≤2500Da的肽含量高达98％以上。
优选的，所述植物油微囊粉由植物油、包埋载体、食品添加剂等经混合配料、乳化、喷雾干燥等主要工艺制备而成；
其中，植物油按照重量比包括如下组分葵花籽油20-35：亚麻籽油5-10。
优选的，所述植物油微囊粉的包埋载体是葡萄糖浆、酪蛋白、低聚麦芽糖、低聚异麦芽糖、低聚木糖中的一种或几种。
优选的，每1g所述维生素预混料包括醋酸维生素A 1429.74-1934.36IU、维生素D3271.66-367.54IU、dl-α-醋酸生育酚3.79-5.13mg、植物甲萘醌0.03-0.04mg、硝酸硫胺素1.24-1.68mg、核黄素1.24-1.68mg、盐酸吡哆醇1.24-1.68mg、氰钴胺0.62-0.83μg、烟酰胺5.21-7.05mg、叶酸0.134-0.181mg、D-泛酸钙2.00-2.88mg、L-抗坏血酸钠43.38-58.67mg、生物素19.87-26.89mg、酒石酸氢胆碱125.21-169.41mg、左旋肉碱42.50-57.50mg、牛磺酸32.64-44.16mg，余料为维生素预混料载体。
优选的，每1g所述矿物质预混料包括柠檬酸钠67.12-100.68mg、磷酸氢二钾56.7-76.7mg、氯化钾100.82-136.26mg、硫酸铜0.05-0.07mg、碳酸镁17.21-23.29mg、焦磷酸铁2.29-3.10mg、氧化锌0.87-1.31mg、硫酸锰0.18-0.27mg、碳酸钙21.96-29.72mg、磷酸氢钙41.4-56.02mg、碘化钾7.14-10.71μg及亚硒酸钠4.69-7.03μg，余料为矿物质预混料载体。
优选的，每1g所述矿物质预混料包括柠檬酸钠83.9mg、磷酸氢二钾66.64mg、氯化钾118.54mg、硫酸铜0.06mg、碳酸镁20.25mg、焦磷酸铁2.75mg、氧化锌1.09mg、硫酸锰0.23mg、碳酸钙25.84mg、磷酸氢钙48.71mg、碘化钾8.93μg及亚硒酸钠5.86μg，余料为矿物质预混料载体。
与现有技术相比，本发明的有益效果是：本发明的一种含可溶性膳食纤维的预消化型全营养配方食品，与现有技术相比，其产品组分全面、丰富，易于机体消化吸收，特别添加低聚果糖、低聚异麦芽糖、低聚木糖等可溶性膳食纤维，通过各组分的协同作用，在保证病人合理膳食的基础上最大限度减少病人肠道负担，促进急慢性胰腺炎、腹泻、炎症性肠道疾病等胃肠道功能不足或部分缺失状态下的患者疾病的康复。
附图说明
图1为本发明的一种含可溶性膳食纤维的预消化型全营养配方食品的制备流程示意图。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合附图及实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。
实施例1
本实施例提供一种技术方案：一种含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品，每100g含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有：低纤维碳水化合物63.635g，乳肽17.5g，中链甘油三酯5.0g，植物油微囊粉7.0g，柠檬酸钠419.5mg，磷酸氢二钾333.2mg，氯化钾592.7mg，硫酸铜0.3mg，碳酸镁101.25mg，焦磷酸铁13.75mg，氧化锌5.45mg，硫酸锰1.15mg，碳酸钙129.2mg，磷酸氢钙243.55mg，碘化钾44.65μg，亚硒酸钠29.3μg，醋酸维生素A 1682.05IU，维生素D3319.6IU，dl-α-醋酸生育酚4.46mg，植物甲萘醌0.035mg，硝酸硫胺素1.46mg，核黄素1.46mg，盐酸吡哆醇1.46mg，氰钴胺0.72μg，烟酰胺6.13mg，叶酸0.157mg，D-泛酸钙2.44mg，L-抗坏血酸钠51.02mg，生物素23.38mg，酒石酸氢胆碱147.31mg，左旋肉碱50mg，牛磺酸38.4mg，阿拉伯胶0.8g，食用香精0.05g，三氯蔗糖0.015g。制得的产品得率为95.84％。
请参阅图1，按照如下步骤制备成品：按比例称取各物料，经风淋、隧道杀菌、配料、筛分、预混、总混、金属探测、灌装等主要工艺过程即制得成品。产品得率约为95.84％。
本实施例的各原料组分比如下表1所示：
| 单位 | 每100g | 单位 | 每100g | ||
| 能量 | kJ | 1695 | 钠 | mg | 524 |
| 蛋白质 | g | 16.5 | 钾 | mg | 626 |
| 脂肪 | g | 7.28 | 铜 | μg | 402 |
| 亚油酸 | g | 1.83 | 镁 | mg | 110 |
| α-亚麻酸 | mg | 364 | 铁 | mg | 7.75 |
| 碳水化合物 | g | 66.2 | 锌 | mg | 5.16 |
| 维生素A | μgRE | 518 | 锰 | μg | 1170 |
| 维生素D | μg | 8.71 | 钙 | mg | 416 |
| 维生素E | mgα-TE | 5.61 | 磷 | mg | 240 |
| 维生素K<sub>1</sub> | μg | 31.5 | 碘 | μg | 48 |
| 维生素B<sub>1</sub> | mg | 1.43 | 氯 | mg | 290 |
| 维生素B<sub>2</sub> | mg | 1.43 | 硒 | μg | 32.9 |
| 维生素B<sub>6</sub> | mg | 1.38 | 胆碱 | mg | 158 |
| 维生素B<sub>12</sub> | μg | 2.49 | 牛磺酸 | mg | 37.3 |
| 烟酸 | μg | 6006 | 左旋肉碱 | mg | 52.4 |
| 叶酸 | μg | 146.1 | 低聚果糖 | g | 2.10 |
| 泛酸 | mg | 2.72 | |||
| 维生素C | mg | 96.5 | |||
| 生物素 | μg | 24.17 |
实施例2
本实施例提供一种技术方案：一种含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品，每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有：低纤维碳水化合物63.635g，乳肽17.5g，中链甘油三酯5.0g，植物油微囊粉7.0g，柠檬酸钠419.5mg，磷酸氢二钾333.2mg，氯化钾592.7mg，硫酸铜0.3mg，碳酸镁101.25mg，焦磷酸铁13.75mg，氧化锌5.45mg，硫酸锰1.15mg，碳酸钙129.2mg，磷酸氢钙243.55mg，碘化钾44.65μg，亚硒酸钠29.3μg，醋酸维生素A 1682.05IU，维生素D3319.6IU，dl-α-醋酸生育酚4.46mg，植物甲萘醌0.035mg，硝酸硫胺素1.46mg，核黄素1.46mg，盐酸吡哆醇1.46mg，氰钴胺0.72μg，烟酰胺6.13mg，叶酸0.157mg，D-泛酸钙2.44mg，L-抗坏血酸钠51.02mg，生物素23.38mg，酒石酸氢胆碱147.31mg，左旋肉碱50mg，牛磺酸38.4mg，阿拉伯胶0.8g，食用香精0.05g，三氯蔗糖0.015g。
制备方法：与实施例1相同。产品得率约为96.24％。
本实施例的各原料组分比如下表2所示：
实施例3
本实施例提供一种技术方案：一种含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品，每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有：低纤维碳水化合物63.635g，乳肽17.5g，中链甘油三酯5.0g，植物油微囊粉7.0g，柠檬酸钠419.5mg，磷酸氢二钾333.2mg，氯化钾592.7mg，硫酸铜0.3mg，碳酸镁101.25mg，焦磷酸铁13.75mg，氧化锌5.45mg，硫酸锰1.15mg，碳酸钙129.2mg，磷酸氢钙243.55mg，碘化钾44.65μg，亚硒酸钠29.3μg，醋酸维生素A 1682.05IU，维生素D3319.6IU，dl-α-醋酸生育酚4.46mg，植物甲萘醌0.035mg，硝酸硫胺素1.46mg，核黄素1.46mg，盐酸吡哆醇1.46mg，氰钴胺0.72μg，烟酰胺6.13mg，叶酸0.157mg，D-泛酸钙2.44mg，L-抗坏血酸钠51.02mg，生物素23.38mg，酒石酸氢胆碱147.31mg，左旋肉碱50mg，牛磺酸38.4mg，阿拉伯胶0.8g，食用香精0.05g，三氯蔗糖0.015g。
制备方法：与实施例1相同。产品得率约为96.08％。
本实施例的各原料组分比如下表3所示：
表3
本发明的一种含可溶性膳食纤维的预消化型全营养配方食品，其制备方法操作简单，相较于湿法工艺，其生产过程中营养素的损失较少，营养素指标控制精确，适合大规模工业化生产的应用。产品组分全面、丰富，易于机体消化吸收，特别添加低聚果糖、低聚异麦芽糖、低聚木糖等可溶性膳食纤维，通过各组分的协同作用，在保证病人合理膳食的基础上最大限度减少病人肠道负担，促进急慢性胰腺炎、腹泻、炎症性肠道疾病等胃肠道功能不足或部分缺失状态下的患者疾病的康复。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明的保护范围之内。
Claims (10)
1.一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有：低纤维碳水化合物52.5-68.5g，乳肽12-22g，中链甘油三酯4-8g，植物油微囊粉4.5-10g，矿物质预混料4.0-6.0g，维生素预混料0.8-1.2g，阿拉伯胶0.5-1.0g，食用香精0.02-0.10g，三氯蔗糖0.01-0.05g。
2.如权利要求1所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有：低纤维碳水化合物63.635g，乳肽17.5g，中链甘油三酯5.0g，植物油微囊粉7.0g，矿物质预混料5.0g，维生素预混料1.0g，阿拉伯胶0.8g，食用香精0.05g，三氯蔗糖0.015g。
3.如权利要求1所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有麦芽糊精56-62g、低聚果糖1.5-2.5g。
4.如权利要求3所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：每100g所述含可溶性膳食纤维的预消化型特殊医学用途全营养配方食品中含有麦芽糊精61.635g、低聚果糖2.0g。
5.如权利要求1所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：所述乳肽经蛋白酶水解后以二肽、三肽和寡肽为主，分子量Mw≤2500Da的肽含量高达98％以上。
6.如权利要求1所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：所述植物油微囊粉由植物油、包埋载体、食品添加剂等经混合配料、乳化、喷雾干燥等主要工艺制备而成；
其中，植物油按照重量比包括如下组分葵花籽油20-35：亚麻籽油5-10。
7.如权利要求6所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：所述植物油微囊粉的包埋载体是葡萄糖浆、酪蛋白、低聚麦芽糖、低聚异麦芽糖、低聚木糖中的一种或几种。
8.如权利要求1所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：每1g所述维生素预混料包括醋酸维生素A 1429.74-1934.36IU、维生素D3 271.66-367.54IU、dl-α-醋酸生育酚3.79-5.13mg、植物甲萘醌0.03-0.04mg、硝酸硫胺素1.24-1.68mg、核黄素1.24-1.68mg、盐酸吡哆醇1.24-1.68mg、氰钴胺0.62-0.83μg、烟酰胺5.21-7.05mg、叶酸0.134-0.181mg、D-泛酸钙2.00-2.88mg、L-抗坏血酸钠43.38-58.67mg、生物素19.87-26.89mg、酒石酸氢胆碱125.21-169.41mg、左旋肉碱42.50-57.50mg、牛磺酸32.64-44.16mg，余料为维生素预混料载体。
9.如权利要求1所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：每1g所述矿物质预混料包括柠檬酸钠67.12-100.68mg、磷酸氢二钾56.7-76.7mg、氯化钾100.82-136.26mg、硫酸铜0.05-0.07mg、碳酸镁17.21-23.29mg、焦磷酸铁2.29-3.10mg、氧化锌0.87-1.31mg、硫酸锰0.18-0.27mg、碳酸钙21.96-29.72mg、磷酸氢钙41.4-56.02mg、碘化钾7.14-10.71μg及亚硒酸钠4.69-7.03μg，余料为矿物质预混料载体。
10.如权利要求1所述的一种含可溶性膳食纤维的预消化型全营养配方食品，其特征在于：每1g所述矿物质预混料包括柠檬酸钠83.9mg、磷酸氢二钾66.64mg、氯化钾118.54mg、硫酸铜0.06mg、碳酸镁20.25mg、焦磷酸铁2.75mg、氧化锌1.09mg、硫酸锰0.23mg、碳酸钙25.84mg、磷酸氢钙48.71mg、碘化钾8.93μg及亚硒酸钠5.86μg，余料为矿物质预混料载体。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110415741.6A CN113142563A (zh) | 2021-04-19 | 2021-04-19 | 一种含可溶性膳食纤维的预消化型全营养配方食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110415741.6A CN113142563A (zh) | 2021-04-19 | 2021-04-19 | 一种含可溶性膳食纤维的预消化型全营养配方食品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113142563A true CN113142563A (zh) | 2021-07-23 |
Family
ID=76868258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110415741.6A Pending CN113142563A (zh) | 2021-04-19 | 2021-04-19 | 一种含可溶性膳食纤维的预消化型全营养配方食品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113142563A (zh) |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102379392A (zh) * | 2011-10-21 | 2012-03-21 | 杭州纸友科技有限公司 | 一种肠健康食品及其制备方法 |
| CN105285984A (zh) * | 2015-10-27 | 2016-02-03 | 江西美庐乳业集团有限公司 | 一种能调节肠道微生态环境，改善宝宝贫血、厌食的营养包 |
| CN108783437A (zh) * | 2018-06-29 | 2018-11-13 | 山东探克生物科技股份有限公司 | 一种预消化的炎性肠病全营养配方食品及其制备工艺 |
| CN110367341A (zh) * | 2019-08-09 | 2019-10-25 | 镇江市智农食品有限公司 | 一种应用于谷物冲剂的植物油微囊粉及其制备方法 |
| CN110638042A (zh) * | 2019-11-04 | 2020-01-03 | 光明乳业股份有限公司 | 一种全营养配方食品及其应用 |
| CN110638043A (zh) * | 2019-11-04 | 2020-01-03 | 光明乳业股份有限公司 | 一种富含益生菌的全营养配方食品及其制备方法与应用 |
| JP2020178685A (ja) * | 2019-04-23 | 2020-11-05 | 学校法人慶應義塾 | 腸管障害の予防、治療又は抑制用組成物 |
| CN112385827A (zh) * | 2020-09-24 | 2021-02-23 | 特康药业集团有限公司 | 高能量密度酪蛋白型全营养特医食品乳剂及其制备方法 |
-
2021
- 2021-04-19 CN CN202110415741.6A patent/CN113142563A/zh active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102379392A (zh) * | 2011-10-21 | 2012-03-21 | 杭州纸友科技有限公司 | 一种肠健康食品及其制备方法 |
| CN105285984A (zh) * | 2015-10-27 | 2016-02-03 | 江西美庐乳业集团有限公司 | 一种能调节肠道微生态环境，改善宝宝贫血、厌食的营养包 |
| CN108783437A (zh) * | 2018-06-29 | 2018-11-13 | 山东探克生物科技股份有限公司 | 一种预消化的炎性肠病全营养配方食品及其制备工艺 |
| JP2020178685A (ja) * | 2019-04-23 | 2020-11-05 | 学校法人慶應義塾 | 腸管障害の予防、治療又は抑制用組成物 |
| CN110367341A (zh) * | 2019-08-09 | 2019-10-25 | 镇江市智农食品有限公司 | 一种应用于谷物冲剂的植物油微囊粉及其制备方法 |
| CN110638042A (zh) * | 2019-11-04 | 2020-01-03 | 光明乳业股份有限公司 | 一种全营养配方食品及其应用 |
| CN110638043A (zh) * | 2019-11-04 | 2020-01-03 | 光明乳业股份有限公司 | 一种富含益生菌的全营养配方食品及其制备方法与应用 |
| CN112385827A (zh) * | 2020-09-24 | 2021-02-23 | 特康药业集团有限公司 | 高能量密度酪蛋白型全营养特医食品乳剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0721742B1 (en) | Nutrition for elderly patients | |
| US8557299B2 (en) | Dietary supplement containing alkaline electrolyte butters | |
| CN110226741A (zh) | 一种溃疡性结肠炎专用型临床营养配方及其制备方法 | |
| CN110742267B (zh) | 一种炎性肠病全营养配方食品 | |
| CN109393493A (zh) | 一种含hmb钙的预消化型全营养液及其制备方法 | |
| CN111418833A (zh) | 作为糖尿病人群单一营养来源的低gi全营养配方粉及其制备方法 | |
| CN110638043A (zh) | 一种富含益生菌的全营养配方食品及其制备方法与应用 | |
| CN110638042A (zh) | 一种全营养配方食品及其应用 | |
| CN112690457A (zh) | 一种用于超重和肥胖人群的营养素组合物配方 | |
| CN108703376A (zh) | 一种短肽型肠内营养多聚合剂 | |
| CN112868803A (zh) | 一种提高母乳营养的配方奶粉及其制备方法 | |
| CN113142563A (zh) | 一种含可溶性膳食纤维的预消化型全营养配方食品 | |
| CN107467193A (zh) | 一种以羊奶为基础的粉剂全营养特殊医学用途配方食品及其制备方法 | |
| CN111165802A (zh) | 一种用于肾病非透析患者的医用营养粉及制备方法 | |
| CN110742266B (zh) | 一种辅助调节肠道免疫功能的全营养配方食品 | |
| US20140335221A1 (en) | Temporally meal menu for infants | |
| US9357797B2 (en) | Dietary supplement containing alkaline electrolyte buffers | |
| NZ520605A (en) | Oral administration of a nutritional supplement containing at least 5.5% threonine increase mucin synthesis | |
| CN108782764A (zh) | 预防结肠炎的婴幼儿奶粉及其制备方法 | |
| CN117084403A (zh) | 一种营养组合物及其制备方法和用途 | |
| KR20070049376A (ko) | 다이어트 음료 조성물 | |
| CN115836701A (zh) | 一种调节胃肠功能的糖及其制备方法 | |
| CN117598475A (zh) | 一种成人特殊医学用途全营养配方食品及其制备方法 | |
| CN118077904A (zh) | 一种特殊医学用途流质配方食品及制备方法和应用 | |
| CN114747690A (zh) | 一种提高蛋鸡蛋壳质量的预混合饲料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210723 |
|
| RJ01 | Rejection of invention patent application after publication |